NPPA fixes retail price of 10 combo drugs including Metformin, Rosuvastatin; Details Farhat Nasim16 Aug 2019 10:31 AM GMTNew Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
NPPA fixes retail price of 9 combo drugs including Metformin, Paracetamol; Details Farhat Nasim4 July 2019 9:10 AM GMTNew Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail...
NPPA fixes retail price of 18 commonly used formulations including Metformin, Atorvastatin; Details Farhat Nasim4 Jun 2019 12:14 PM GMTNew Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail...
NPPA revises ceiling price of 847 formulations including Metformin, Atrovastatin; Details Meghna A Singhania3 April 2019 12:38 PM GMTNew Delhi: Through a recent notification, National Pharmaceutical Pricing Authority (NPPA) has fixed the ceiling prices of 847 formulations under the...
NATHEALTH appoints Manipal Health Enterprise Chairman Dr Sudarshan Ballal as president for 2019-20 Meghna A Singhania23 March 2019 8:01 AM GMTManipal Health ChairmanSudarshan Ballal succeeds Fortis Healthcare's Daljit Singh as the president, the Healthcare Federation of India (NATHEALTH)...
Lupin to lays off employees from RnD Divsion Farhat Nasim15 March 2019 12:31 PM GMTMumbai: Facing a Setback in its business turf, one the largest manufacturers of medicines in the country Lupin Ltd is taking steps to rationalize its...
GSK Consumer profit rises 35 percent to Rs 221.06 crore in December quarter Garima16 Feb 2019 3:50 AM GMT"The merger is now subject to the receipt of other necessary statutory and regulatory approvals under applicable laws. The merger process is moving...
Price control, ad-hoc regulatory changes may hamper pharma sector growth: Pfizer Ruby Khatun Khatun3 Sep 2018 5:00 AM GMTMumbai: Pharma major Pfizer fears that the pharma industry is expected to face challenges from price controls, ad-hoc regulatory changes and new...
Dabur sues government for denied tax sops under GST Ruby Khatun Khatun23 Jun 2018 6:18 PM GMTMUMBAI: Central and Uttarakhand government have been dragged to court by Dabur for rejecting tax sops for investment in poorer areas promised under...
NPPA slashes price of 39 drugs: check out details Ruby Khatun Khatun21 Sep 2017 5:04 AM GMTNew Delhi: Drug price regulator NPPA on Wednesday said it has fixed the ceiling price for 39 more drug formulations, including those used for the...
Abbott India Q1 net profit down 35 percent at Rs 48 crore Ruby Khatun Khatun10 Aug 2017 3:46 AM GMTNew Delhi: Pharmaceuticals firm Abbott India on Tuesday reported 34.8 per cent decline in net profit to Rs 48.25 crore for the first quarter ended...
